Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share (Details Narrative)

v3.20.1
Loss Per Share (Details Narrative) - shares
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Options and warrants outstanding to acquire shares of common stock 3,082,000 2,950,000
Common Stock Equivalents [Member]    
Common stock equivalent and options excluded from earnings (loss) per share computation as anti-dilutive effect 3,082,000 2,950,000